Infectious and noninfectious triggers in Guillain–Barré syndrome

References

• Guillain G, Barré JA, Strohl A. Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide céphalo-rachidien sans réaction cellulaire: remarques sur les caractères cliniques et graphiques des réflexes tendineux. Bulletins et mémoires de la Société des Médecins des Hôpitaux de Paris 40, 1462–1470 (1916).
   Google Scholar
• Yuki N, Hartung HP. Guillain–Barré syndrome. N. Engl. J. Med. 366(24), 2294–2304 (2012).
   PubMed Web of Science ®Google Scholar
• Campbell AM. The aetiology of polyneuritis. Proc. R. Soc. Med. 51(3), 157–159 (1958).
   PubMedGoogle Scholar
• Ropper AH. The Guillain–Barré syndrome. N. Engl. J. Med. 326(17), 1130–1136 (1992).
   PubMed Web of Science ®Google Scholar
• Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain–Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology 36(2), 123–133 (2011).
   PubMed Web of Science ®Google Scholar
• Zhang M, Li Q, He L et al. Association study between an outbreak of Guillain–Barré syndrome in Jilin, China, and preceding Campylobacter jejuni infection. Foodborne Pathog. Dis. 7(8), 913–919 (2010).
   PubMed Web of Science ®Google Scholar
• McKhann GM, Cornblath DR, Griffin JW et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann. Neurol. 33(4), 333–342 (1993).
   PubMed Web of Science ®Google Scholar
• Kokubun N, Nishibayashi M, Uncini A, Odaka M, Hirata K, Yuki N. Conduction block in acute motor axonal neuropathy. Brain 133(10), 2897–2908 (2010).
   PubMed Web of Science ®Google Scholar
• Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N. Engl. J. Med. 255(2), 57–65 (1956).
   PubMed Web of Science ®Google Scholar
• Bickerstaff ER. Brain-stem encephalitis; further observations on a grave syndrome with benign prognosis. Br. Med. J. 1(5032), 1384–1387 (1957).
   PubMed Web of Science ®Google Scholar
• Sejvar JJ, Kohl KS, Gidudu J et al.; Brighton Collaboration GBS Working Group. Guillain–Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29(3), 599–612 (2011).
   PubMed Web of Science ®Google Scholar
• Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) 48(3), 173–215 (1969).
   PubMed Web of Science ®Google Scholar
• Hafer-Macko C, Hsieh ST, Li CY et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann. Neurol. 40(4), 635–644 (1996).
   PubMed Web of Science ®Google Scholar
• Hafer-Macko CE, Sheikh KA, Li CY et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann. Neurol. 39(5), 625–635 (1996).
   PubMed Web of Science ®Google Scholar
• Mori M, Kuwabara S, Miyake M et al. Haemophilus influenzae infection and Guillain–Barré syndrome. Brain 123(Pt 10), 2171–2178 (2000).
   PubMed Web of Science ®Google Scholar
• Koga M, Kusunoki S, Kaida K et al. Nationwide survey of patients in Japan with Bickerstaff brainstem encephalitis: epidemiological and clinical characteristics. J. Neurol. Neurosurg. Psychiatr. 83(12), 1210–1215 (2012).
   PubMed Web of Science ®Google Scholar
• Furtado D. [Pathogenesis of Guillain–Barré syndrome]. Monatsschr. Psychiatr. Neurol. 119(5), 264–273 (1950).
   PubMedGoogle Scholar
• Haymaker WE, Kernohan JW. The Landry–Guillain–Barré syndrome; a clinicopathologic report of 50 fatal cases and a critique of the literature. Medicine (Baltimore) 28(1), 59–141 (1949).
   PubMed Web of Science ®Google Scholar
• Melnick SC, Flewett TH. Role of infection in the Guillain–Barr’e syndrome. J. Neurol. Neurosurg. Psychiatr. 27, 395–407 (1964).
   PubMed Web of Science ®Google Scholar
• Hughes RAC, Rees JH. Clinical and epidemiologic features of Guillain–Barré syndrome. J. Infect. Dis. 176(Suppl. 2), S92–S98 (1997).
   PubMed Web of Science ®Google Scholar
• Poropatich KO, Walker CL, Black RE. Quantifying the association between Campylobacter infection and Guillain–Barré syndrome: a systematic review. J. Health. Popul. Nutr. 28(6), 545–552 (2010).
   PubMed Web of Science ®Google Scholar
• Jacobs BC, Rothbarth PH, van der Meché FGA et al. The spectrum of antecedent infections in Guillain–Barré syndrome: a case–control study. Neurology 51(4), 1110–1115 (1998).
   PubMed Web of Science ®Google Scholar
• Rhodes KM, Tattersfield AE. Guillain–Barré syndrome associated with Campylobacter infection. Br. Med. J. (Clin. Res. Ed.) 285(6336), 173–174 (1982).
   PubMed Web of Science ®Google Scholar
• Young KT, Davis LM, Dirita VJ. Campylobacter jejuni: molecular biology and pathogenesis. Nat. Rev. Microbiol. 5(9), 665–679 (2007).
   PubMed Web of Science ®Google Scholar
• Friedman CR, Neimann J, Wegener HC, Tauxe RV. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In: Campylobacter. (2nd Edition). Nachamkin I, Blaser MJ (Eds). ASM Press, Washington, DC, USA, 121–138 (2000).
   Google Scholar
• Suchodolski JS. Companion animals symposium: microbes and gastrointestinal health of dogs and cats. J. Anim. Sci. 89(5), 1520–1530 (2011).
   PubMed Web of Science ®Google Scholar
• Nachamkin I. Campylobacter and Arcobacter. In: Manual of Clinical Microbiology (6th Edition). Murray PR, Barron EJ, Pfaller MA, Tenover FC, Yolken RH (Eds). American Society for Microbiology, Washington, DC, USA 483−491 (1995).
   Google Scholar
• Allos BM. Association between Campylobacter infection and Guillain–Barré syndrome. J. Infect. Dis. 176(Suppl. 2), S125–S128 (1997).
   PubMed Web of Science ®Google Scholar
• Takahashi M, Koga M, Yokoyama K, Yuki N. Epidemiology of Campylobacter jejuni isolated from patients with Guillain–Barré and Fisher syndromes in Japan. J. Clin. Microbiol. 43(1), 335–339 (2005).
   PubMed Web of Science ®Google Scholar
• Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter jejuni infection and Guillain–Barré syndrome. N. Engl. J. Med. 333(21), 1374–1379 (1995).
   PubMed Web of Science ®Google Scholar
• Kuwabara S, Ogawara K, Misawa S et al. Does Campylobacter jejuni infection elicit “demyelinating” Guillain–Barré syndrome? Neurology 63(3), 529–533 (2004).
   PubMed Web of Science ®Google Scholar
• Drenthen J, Yuki N, Meulstee J et al. Guillain–Barré syndrome subtypes related to Campylobacter infection. J. Neurol. Neurosurg. Psychiatr. 82(3), 300–305 (2011).
   PubMed Web of Science ®Google Scholar
• Kokubun N, Shahrizaila N, Hirata K, Yuki N. Conduction block and axonal degeneration co-occurring in a patient with axonal Guillain–Barré syndrome. J. Neurol. Sci. 319(1–2), 164–167 (2012).
   PubMed Web of Science ®Google Scholar
• Ang CW, Jacobs BC, Laman JD. The Guillain–Barré syndrome: a true case of molecular mimicry. Trends Immunol. 25(2), 61–66 (2004).
   PubMed Web of Science ®Google Scholar
• Shahrizaila N, Yuki N. Guillain–Barré syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder. J. Biomed. Biotechnol. 2011, 829129 (2011).
   PubMedGoogle Scholar
• Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 40(12), 1900–1902 (1990).
   PubMed Web of Science ®Google Scholar
• Ho TW, Willison HJ, Nachamkin I et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain–Barré syndrome. Ann. Neurol. 45(2), 168–173 (1999).
   PubMed Web of Science ®Google Scholar
• Yuki N, Taki T, Inagaki F et al. A bacterium lipopolysaccharide that elicits Guillain–Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178(5), 1771–1775 (1993).
   PubMed Web of Science ®Google Scholar
• Koga M, Gilbert M, Li J et al. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 64(9), 1605–1611 (2005).
   PubMed Web of Science ®Google Scholar
• Yuki N, Yamada M, Koga M et al. Animal model of axonal Guillain–Barré syndrome induced by sensitization with GM1 ganglioside. Ann. Neurol. 49(6), 712–720 (2001).
   PubMed Web of Science ®Google Scholar
• Yuki N, Susuki K, Koga M et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain–Barré syndrome. Proc. Natl Acad. Sci. USA 101(31), 11404–11409 (2004).
   PubMed Web of Science ®Google Scholar
• Houliston RS, Koga M, Li J et al. A Haemophilus influenzae strain associated with Fisher syndrome expresses a novel disialylated ganglioside mimic. Biochemistry 46(27), 8164–8171 (2007).
   PubMed Web of Science ®Google Scholar
• Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain–Barré syndrome: clinical and immunohistochemical studies. Neurology 43(10), 1911–1917 (1993).
   PubMed Web of Science ®Google Scholar
• Susuki K, Yuki N, Hirata K. Fine specificity of anti-GQ1b IgG and clinical features. J. Neurol. Sci. 185(1), 5–9 (2001).
   PubMed Web of Science ®Google Scholar
• Liu JX, Willison HJ, Pedrosa-Domellöf F. Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest. Ophthalmol. Vis. Sci. 50(7), 3226–3232 (2009).
   PubMed Web of Science ®Google Scholar
• Yuki N, Yoshino H, Sato S, Shinozawa K, Miyatake T. Severe acute axonal form of Guillain–Barré syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve 15(8), 899–903 (1992).
   PubMed Web of Science ®Google Scholar
• Penner JL, Hennessy JN. Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J. Clin. Microbiol. 12(6), 732–737 (1980).
   PubMed Web of Science ®Google Scholar
• Nishimura M, Nukina M, Kuroki S et al. Characterization of Campylobacter jejuni isolates from patients with Guillain–Barré syndrome. J. Neurol. Sci. 153(1), 91–99 (1997).
   PubMed Web of Science ®Google Scholar
• Takahashi M, Koga M, Yokoyama K, Yuki N. Epidemiology of Campylobacter jejuni isolated from patients with Guillain–Barré and Fisher syndromes in Japan. J. Clin. Microbiol. 43(1), 335–339 (2005).
   PubMed Web of Science ®Google Scholar
• Endtz HP, Ang CW, van Den Braak N et al. Molecular characterization of Campylobacter jejuni from patients with Guillain–Barré and Miller Fisher syndromes. J. Clin. Microbiol. 38(6), 2297–2301 (2000).
   PubMed Web of Science ®Google Scholar
• Gilbert M, Godschalk PCR, Parker CT, Endtz HP, Wakarchuk WW. Genetic bases for the variation in the lipooligosaccharide outer core of Campylobacter jejuni and possible association of glycosyltransferase genes with post-infectious neuropathies. In: Campylobacter: Molecular and Cellular Biology. Ketley J, Konkel M (Eds). Horizon Scientific Press, Norwich, UK, 219–248 (2005).
   Google Scholar
• Godschalk PC, Heikema AP, Gilbert M et al. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain–Barré syndrome. J. Clin. Invest. 114(11), 1659–1665 (2004).
   PubMed Web of Science ®Google Scholar
• Koga M, Gilbert M, Takahashi M et al. Comprehensive analysis of bacterial risk factors for the development of Guillain–Barré syndrome after Campylobacter jejuni enteritis. J. Infect. Dis. 193(4), 547–555 (2006).
   PubMed Web of Science ®Google Scholar
• Gilbert M, Karwaski MF, Bernatchez S et al. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni: biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J. Biol. Chem. 277(1), 327–337 (2002).
   PubMed Web of Science ®Google Scholar
• Koga M, Takahashi M, Masuda M, Hirata K, Yuki N. Campylobacter gene polymorphism as a determinant of clinical features of Guillain–Barré syndrome. Neurology 65(9), 1376–1381 (2005).
   PubMed Web of Science ®Google Scholar
• Sinha S, Prasad KN, Jain D, Pandey CM, Jha S, Pradhan S. Preceding infections and anti-ganglioside antibodies in patients with Guillain–Barré syndrome: a single centre prospective case–control study. Clin. Microbiol. Infect. 13(3), 334–337 (2007).
   PubMed Web of Science ®Google Scholar
• Sharma MB, Chaudhry R, Tabassum I et al. The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain–Barré syndrome. J. Infect. Dev. Ctries. 5(6), 459–464 (2011).
   PubMed Web of Science ®Google Scholar
• Kusunoki S, Chiba A, Hitoshi S, Takizawa H, Kanazawa I. Anti-Gal-C antibody in autoimmune neuropathies subsequent to Mycoplasma infection. Muscle Nerve 18(4), 409–413 (1995).
   PubMed Web of Science ®Google Scholar
• Kusunoki S, Shiina M, Kanazawa I. Anti-Gal-C antibodies in GBS subsequent to Mycoplasma infection: evidence of molecular mimicry. Neurology 57(4), 736–738 (2001).
   PubMed Web of Science ®Google Scholar
• Susuki K, Odaka M, Mori M, Hirata K, Yuki N. Acute motor axonal neuropathy after Mycoplasma infection: evidence of molecular mimicry. Neurology 62(6), 949–956 (2004).
   PubMed Web of Science ®Google Scholar
• Miller B, Kassenborg H, Dunsmuir W et al. Syndromic surveillance for influenzalike illness in ambulatory care network. Emerging Infect. Dis. 10(10), 1806–1811 (2004).
   PubMed Web of Science ®Google Scholar
• Koga M, Koike S, Hirata K, Yuki N. Ambiguous value of Haemophilus influenzae isolation in Guillain–Barré and Fisher syndromes. J. Neurol. Neurosurg. Psychiatr. 76(12), 1736–1738 (2005).
   PubMed Web of Science ®Google Scholar
• Moran AP, Prendergast MM, Appelmelk BJ. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol. Med. Microbiol. 16(2), 105–115 (1996).
   PubMed Web of Science ®Google Scholar
• Gervaix A, Caflisch M, Suter S, Haenggeli CA. Guillain–Barré syndrome following immunisation with Haemophilus influenzae type b conjugate vaccine. Eur. J. Pediatr. 152(7), 613–614 (1993).
   PubMed Web of Science ®Google Scholar
• Mori M, Kuwabara S, Miyake M et al. Haemophilus influenzae infection and Guillain–Barré syndrome. Brain 123(Pt 10), 2171–2178 (2000).
   PubMed Web of Science ®Google Scholar
• Koga M, Yuki N, Tai T, Hirata K. Miller Fisher syndrome and Haemophilus influenzae infection. Neurology 57(4), 686–691 (2001).
   PubMed Web of Science ®Google Scholar
• Mori M, Kuwabara S, Miyake M et al. Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain–Barré syndrome. Neurology 52(6), 1282–1284 (1999).
   PubMed Web of Science ®Google Scholar
• Nahata MC. Ophthalmoplegia following enteric fever. J. Indian Med. Assoc. 37, 134–135 (1961).
   PubMedGoogle Scholar
• Nager F, Regli F. Polyneuritis with flaccid tetraplegia in typhoid fever. Schweiz. Med. Wochenschr. 93, 1030–1033 (1963).
   PubMedGoogle Scholar
• Samantray SK, Johnson SC, Mathai KV, Pulimood BM. Landry–Guillain–Barré–Strohl syndrome. A study of 302 cases. Med. J. Aust. 2(3), 84–91 (1977).
   PubMed Web of Science ®Google Scholar
• Osuntokun BO, Bademosi O, Ogunremi K, Wright SG. Neuropsychiatric manifestations of typhoid fever in 959 patients. Arch. Neurol. 27(1), 7–13 (1972).
   PubMedGoogle Scholar
• Khan FY, Kamha AA, Abbas MT, Miyares F, Elshafie SS. Guillain–Barré syndrome associated with Salmonella paratyphi A. Clin. Neurol. Neurosurg. 109(5), 452–454 (2007).
   PubMed Web of Science ®Google Scholar
• Sheng B, Ho WS, Lau KK, Lui DC, Lam BH, Chan EY. Bickerstaff’s brainstem encephalitis complicating Salmonella Paratyphi A infection. J. Neurol. Sci. 302(1–2), 108–111 (2011).
   PubMed Web of Science ®Google Scholar
• Klemola E, Weckman N, Haltia K, Kääriäinen L. The Guillain–Barré syndrome associated with acquired cytomegalovirus infection. Acta Med. Scand. 181(5), 603–607 (1967).
   PubMedGoogle Scholar
• Yuki N, Tagawa Y. Acute cytomegalovirus infection and IgM anti-GM2 antibody. J. Neurol. Sci. 154(1), 14–17 (1998).
   PubMed Web of Science ®Google Scholar
• Orlikowski D, Porcher R, Sivadon-Tardy V et al. Guillain–Barré syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin. Infect. Dis. 52(7), 837–844 (2011).
   PubMed Web of Science ®Google Scholar
• Sinclair J, Sissons P. Latency and reactivation of human cytomegalovirus. J. Gen. Virol. 87(Pt 7), 1763–1779 (2006).
   PubMed Web of Science ®Google Scholar
• Visser LH, van der Meché FGA, Meulstee J et al. Cytomegalovirus infection and Guillain–Barré syndrome: the clinical, electrophysiologic, and prognostic features. Neurology 47(3), 668–673 (1996).
   PubMed Web of Science ®Google Scholar
• Kang JH, Sheu JJ, Lin HC. Increased risk of Guillain–Barré Syndrome following recent herpes zoster: a population-based study across Taiwan. Clin. Infect. Dis. 51(5), 525–530 (2010).
   PubMed Web of Science ®Google Scholar
• Bitan M, Or R, Shapira MY et al. Early-onset Guillain–Barré syndrome associated with reactivation of Epstein–Barr virus infection after nonmyeloablative stem cell transplantation. Clin. Infect. Dis. 39(7), 1076–1078 (2004).
   PubMed Web of Science ®Google Scholar
• Tam CC, O’Brien SJ, Petersen I, Islam A, Hayward A, Rodrigues LC. Guillain–Barré syndrome and preceding infection with campylobacter, influenza and Epstein–Barr virus in the general practice research database. PLoS ONE 2(4), e344 (2007).
   PubMed Web of Science ®Google Scholar
• Stowe J, Andrews N, Wise L, Miller E. Investigation of the temporal association of Guillain–Barré syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am. J. Epidemiol. 169(3), 382–388 (2009).
   PubMed Web of Science ®Google Scholar
• Sivadon-Tardy V, Orlikowski D, Porcher R et al. Guillain–Barré syndrome and influenza virus infection. Clin. Infect. Dis. 48(1), 48–56 (2009).
   PubMed Web of Science ®Google Scholar
• Cortese A, Baldanti F, Tavazzi E et al. Guillain–Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: case report and review of the literature. J. Neurol. Sci. 312(1-2), 173–176 (2012).
   PubMed Web of Science ®Google Scholar
• Kutlesa M, Santini M, Krajinovic V, Raffanelli D, Barsic B. Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection. Neurocrit. Care 13(1), 98–100 (2010).
   PubMed Web of Science ®Google Scholar
• Grimaldi-Bensouda L, Alpérovitch A, Besson G et al. Guillain-Barré syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am. J. Epidemiol. 174(3), 326–335 (2011).
   PubMed Web of Science ®Google Scholar
• Simpson BS, Rajabally YA. Sensori-motor Guillain–Barré syndrome with anti-GD1b antibodies following influenza A infection. Eur. J. Neurol. 16(4), e81 (2009).
   PubMedGoogle Scholar
• Yuki N, Takahashi Y, Ihara T et al. Lack of antibody response to Guillain–Barré syndrome-related gangliosides in mice and men after novel flu vaccination. J. Neurol. Neurosurg. Psychiatr. 83(1), 116–117 (2012).
   PubMed Web of Science ®Google Scholar
• Beadling C, Slifka MK. How do viral infections predispose patients to bacterial infections? Curr. Opin. Infect. Dis. 17(3), 185–191 (2004).
   PubMed Web of Science ®Google Scholar
• Cornblath DR, McArthur JC, Kennedy PG, Witte AS, Griffin JW. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann. Neurol. 21(1), 32–40 (1987).
   PubMed Web of Science ®Google Scholar
• Wagner JC, Bromberg MB. HIV infection presenting with motor axonal variant of Guillain–Barré syndrome. J. Clin. Neuromuscul. Dis. 9(2), 303–305 (2007).
   PubMedGoogle Scholar
• Hiraga A, Kuwabara S, Nakamura A, Yuki N, Hattori T, Matsunaga T. Fisher/Gullain-Barré overlap syndrome in advanced AIDS. J. Neurol. Sci. 258(1–2), 148–150 (2007).
   PubMed Web of Science ®Google Scholar
• Berger JR, Difini JA, Swerdloff MA, Ayyar DR. HIV seropositivity in Guillain–Barré syndrome. Ann. Neurol. 22(3), 393–394 (1987).
   PubMed Web of Science ®Google Scholar
• Piette AM, Tusseau F, Vignon D et al. Acute neuropathy coincident with seroconversion for anti-LAV/HTLV-III. Lancet 1(8485), 852 (1986).
   PubMed Web of Science ®Google Scholar
• Parry O, Mielke J, Latif AS, Ray S, Levy LF, Siziya S. Peripheral neuropathy in individuals with HIV infection in Zimbabwe. Acta Neurol. Scand. 96(4), 218–222 (1997).
   PubMed Web of Science ®Google Scholar
• Piliero PJ, Fish DG, Preston S et al. Guillain–Barré syndrome associated with immune reconstitution. Clin. Infect. Dis. 36(9), e111–e114 (2003).
   Web of Science ®Google Scholar
• Brannagan TH 3rd, Zhou Y. HIV-associated Guillain–Barré syndrome. J. Neurol. Sci. 208(1–2), 39–42 (2003).
   PubMed Web of Science ®Google Scholar
• Sorvillo FJ, Lieb LE, Waterman SH. Incidence of campylobacteriosis among patients with AIDS in Los Angeles County. J. Acquir. Immune Defic. Syndr. 4(6), 598–602 (1991).
   PubMed Web of Science ®Google Scholar
• Verma A. Epidemiology and clinical features of HIV-1 associated neuropathies. J. Peripher. Nerv. Syst. 6(1), 8–13 (2001).
   PubMed Web of Science ®Google Scholar
• Dalakas MC, Pezeshkpour GH. Neuromuscular diseases associated with human immunodeficiency virus infection. Ann. Neurol. 23(Suppl.), S38–S48 (1988).
   PubMedGoogle Scholar
• Souayah N, Mian NF, Gu Y, Ilyas AA. Elevated anti-sulfatide antibodies in Guillain–Barré syndrome in T cell depleted at end-stage AIDS. J. Neuroimmunol. 188(1-2), 143–145 (2007).
   PubMed Web of Science ®Google Scholar
• Garattini S, Garattini L. Pharmaceutical prescriptions in four European countries. Lancet 342(8881), 1191–1192 (1993).
   PubMed Web of Science ®Google Scholar
• Landi G, D’Alessandro R, Dossi BC, Ricci S, Simone IL, Ciccone A. Guillain–Barré syndrome after exogenous gangliosides in Italy. BMJ 307(6917), 1463–1464 (1993).
   PubMedGoogle Scholar
• Keates T. Gangliosides in Italy. Lancet 343(8889), 108 (1994).
   PubMedGoogle Scholar
• Raschetti R, Maggini M, Popoli P et al. Gangliosides and Guillain–Barré syndrome. J. Clin. Epidemiol. 48(11), 1399–1405 (1995).
   PubMed Web of Science ®Google Scholar
• Govoni V, Granieri E, Tola MR et al. Exogenous gangliosides and Guillain–Barré syndrome: an observational study in the local health district of Ferrara, Italy. Brain 120(Pt 7), 1123–1130 (1997).
   PubMed Web of Science ®Google Scholar
• Govoni V, Granieri E, Manconi M, Capone J, Casetta I. Is there a decrease in Guillain–Barré syndrome incidence after bovine ganglioside withdrawal in Italy?: a population-based study in the Local Health District of Ferrara, Italy. J. Neurol. Sci. 216(1), 99–103 (2003).
   PubMed Web of Science ®Google Scholar
• Illa I, Ortiz N, Gallard E, Juarez C, Grau JM, Dalakas MC. Acute axonal Guillain–Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann. Neurol. 38(2), 218–224 (1995).
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity-‘vaccinosis’: a dangerous liaison? J. Autoimmun. 14(1), 1–10 (2000).
   PubMed Web of Science ®Google Scholar
• Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: what is the evidence? Lancet 362(9396), 1659–1666 (2003).
   PubMed Web of Science ®Google Scholar
• Souayah N, Nasar A, Suri MF, Qureshi AI. Guillain–Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990–2005). J. Clin. Neuromuscul. Dis. 11(1), 1–6 (2009).
   PubMedGoogle Scholar
• Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain–Barré syndrome. Drug Saf. 32(4), 309–323 (2009).
   PubMed Web of Science ®Google Scholar
• Ismail EA, Shabani IS, Badawi M et al. An epidemiologic, clinical, and therapeutic study of childhood Guillain–Barré syndrome in Kuwait: is it related to the oral polio vaccine? J. Child Neurol. 13(10), 488–492 (1998).
   PubMed Web of Science ®Google Scholar
• Velentgas P, Amato AA, Bohn RL et al. Risk of Guillain–Barré syndrome after meningococcal conjugate vaccination. Pharmacoepidemiol. Drug Saf. 21(12), 1350–1358 (2012).
   PubMed Web of Science ®Google Scholar
• Tuttle J, Chen RT, Rantala H, Cherry JD, Rhodes PH, Hadler S. The risk of Guillain–Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. Am. J. Public Health 87(12), 2045–2048 (1997).
   PubMed Web of Science ®Google Scholar
• Kitchener S. Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX. Vaccine 22(17-18), 2103–2105 (2004).
   PubMed Web of Science ®Google Scholar
• Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr. Infect. Dis. J. 19(12), 1127–1134 (2000).
   PubMed Web of Science ®Google Scholar
• Souayah N, Yacoub HA, Khan HM et al. Analysis of data from the CDC/FDA vaccine adverse event reporting system (1990–2009) on Guillain–Barré syndrome after hepatitis vaccination in the USA. J. Clin. Neurosci. 19(8), 1089–1092 (2012).
   PubMed Web of Science ®Google Scholar
• Fritzell B, Plotkin S. Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine. J. Pediatr. 121(3), 355–362 (1992).
   PubMed Web of Science ®Google Scholar
• Marfin AA, Eidex RS, Kozarsky PE, Cetron MS. Yellow fever and Japanese encephalitis vaccines: indications and complications. Infect. Dis. Clin. North Am. 19(1), 151–168 (2005).
   PubMed Web of Science ®Google Scholar
• Sejvar JJ, Labutta RJ, Chapman LE, Grabenstein JD, Iskander J, Lane JM. Neurologic adverse events associated with smallpox vaccination in the United States, 2002–2004. JAMA 294(21), 2744–2750 (2005).
   PubMed Web of Science ®Google Scholar
• Schönberger LB, Bregman DJ, Sullivan-Bolyai JZ et al. Guillain–Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977. Am. J. Epidemiol. 110(2), 105–123 (1979).
   PubMed Web of Science ®Google Scholar
• Nachamkin I, Shadomy SV, Moran AP et al. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain–Barré syndrome. J. Infect. Dis. 198(2), 226–233 (2008).
   PubMed Web of Science ®Google Scholar
• Sencer DJ, Millar JD. Reflections on the 1976 swine flu vaccination program. Emerging Infect. Dis. 12(1), 29–33 (2006).
   PubMed Web of Science ®Google Scholar
• Deeks SL, Lim GH, Simpson MA et al. Estimating background rates of Guillain–Barré syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign. BMC Public Health 11, 329 (2011).
   PubMedGoogle Scholar
• Souayah N, Yacoub HA, Khan HM et al. Guillain–Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990–2009). J. Clin. Neuromuscul. Dis. 14(2), 66–71 (2012).
   PubMedGoogle Scholar
• Salmon DA, Proschan M, Forshee R et al. Association between Guillain–Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet 381(9876), 1461–1468 (2013).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Preliminary results: surveillance for Guillain–Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine: United States, 2009–2010. MMWR Morb. Mortal. Wkly Rep. 59(21), 657–661 (2010).
   PubMedGoogle Scholar
• Burwen DR, Sandhu SK, MaCurdy TE et al. Safety Surveillance Working Group. Surveillance for Guillain–Barré syndrome after influenza vaccination among the Medicare population, 2009–2010. Am. J. Public Health 102(10), 1921–1927 (2012).
   PubMed Web of Science ®Google Scholar
• Baxter R, Lewis N, Bakshi N, Vellozzi C, Klein NP; CISA Network. Recurrent Guillain–Barré syndrome following vaccination. Clin. Infect. Dis. 54(6), 800–804 (2012).
   PubMed Web of Science ®Google Scholar
• Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain–Barré syndrome. Drug Saf. 32(4), 309–323 (2009).
   PubMed Web of Science ®Google Scholar
• Laouini D, Kennou MF, Khoufi S, Dellagi K. Antibodies to human myelin proteins and gangliosides in patients with acute neuroparalytic accidents induced by brain-derived rabies vaccine. J. Neuroimmunol. 91(1–2), 63–72 (1998).
   PubMed Web of Science ®Google Scholar
• Dreesen DW, Fishbein DB, Kemp DT, Brown J. Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization. Vaccine 7(5), 397–400 (1989).
   PubMed Web of Science ®Google Scholar
• Sakai H, Harun FM, Yamamoto N, Yuki N. Contamination with gangliosides in brain-derived rabies vaccine may trigger Guillain–Barré syndrome. J. Neurol. Neurosurg. Psychiatr. 83(4), 467–469 (2012).
   PubMed Web of Science ®Google Scholar
• Slade BA, Leidel L, Vellozzi C et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 302(7), 750–757 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang H, Wu J. Systemic lupus erythematosus associated relapsing polyneuropathy: recurrent Guillain–Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy? Muscle Nerve 44(4), 609–610; author reply 610 (2011).
   PubMed Web of Science ®Google Scholar
• Santiago-Casas Y, Peredo RA, Vilá LM. Efficacy of low-dose intravenous cyclophosphamide in systemic lupus erythematosus presenting with Guillain–Barré syndrome-like acute axonal neuropathies: report of two cases. Lupus 22(3), 324–327 (2013).
   PubMed Web of Science ®Google Scholar
• Aït Benhaddou E, Birouk N, El Alaoui-Faris M et al. Acute Guillain–Barré -like polyradiculoneuritis revealing acute systemic lupus erythematosus: two case studies and review of the literature. Rev. Neurol. (Paris) 159(3), 300–306 (2003).
   PubMed Web of Science ®Google Scholar
• Bingisser R, Speich R, Fontana A, Gmür J, Vogel B, Landis T. Lupus erythematosus and Miller-Fisher syndrome. Arch. Neurol. 51(8), 828–830 (1994).
   PubMedGoogle Scholar
• Santos DP, Spitz M, Oliveira P et al. Overlap of Bickerstaff encephalitis and Guillain–Barré syndrome in a patient with systemic lupus. Arq. Neuropsiquiatr. 67(3B), 904–905 (2009).
   PubMed Web of Science ®Google Scholar
• Korn-Lubetzki I, Abramsky O. Acute and chronic demyelinating inflammatory polyradiculoneuropathy. Association with autoimmune diseases and lymphocyte response to human neuritogenic protein. Arch. Neurol. 43(6), 604–608 (1986).
   PubMedGoogle Scholar
• Awad A, Mathew S, Katirji B. Acute motor axonal neuropathy in association with Sjögren syndrome. Muscle Nerve 42(5), 828–830 (2010).
   PubMed Web of Science ®Google Scholar
• van Laarhoven HW, Rooyer FA, van Engelen BG, van Dalen R, Berden JH. Guillain–Barré syndrome as presenting feature in a patient with lupus nephritis, with complete resolution after cyclophosphamide treatment. Nephrol. Dial. Transplant. 16(4), 840–842 (2001).
   PubMed Web of Science ®Google Scholar
• Falagas ME, Manta KG, Betsi GI, Pappas G. Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin. Rheumatol. 26(5), 663–670 (2007).
   PubMed Web of Science ®Google Scholar
• Julien J, Vital C, Aupy G, Lagueny A, Darriet D, Brechenmacher C. Guillain–Barré syndrome and Hodgkin’s disease: ultrastructural study of a peripheral nerve. J. Neurol. Sci. 45(1), 23–27 (1980).
   PubMed Web of Science ®Google Scholar
• Seffo F, Daw HA. Non-Hodgkin lymphoma and Guillain–Barré syndrome: a rare association. Clin. Adv. Hematol. Oncol. 8(3), 201–203 (2010).
   PubMedGoogle Scholar
• Piras E, Caocci G, Pisano V et al. Guillain–Barré syndrome after human herpesvirus-6 reactivation in unrelated hematopoietic stem cell transplantation. Leuk. Lymphoma 54(6), 1332–1333 (2013).
   PubMed Web of Science ®Google Scholar
• Zhang L, Arrington S, Keung YK. Guillain–Barré syndrome after transplantation. Leuk. Lymphoma 49(2), 291–297 (2008).
   PubMed Web of Science ®Google Scholar
• Bitan M, Or R, Shapira MY et al. Early-onset Guillain–Barré syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation. Clin. Infect. Dis. 39(7), 1076–1078 (2004).
   PubMed Web of Science ®Google Scholar
• Niederkorn JY. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat. Immunol. 7(4), 354–359 (2006).
   PubMed Web of Science ®Google Scholar
• Vaduva C, de Seze J, Volatron AC et al. Severe Guillain–Barré syndrome and pregnancy: two cases with rapid improvement post-partum. Rev. Neurol. (Paris) 162(3), 358–362 (2006).
   PubMed Web of Science ®Google Scholar
• Jaso R, Sierra M, Calleja J, Valero C, Pascual J. Guillain–Barré syndrome after rituximab in a patient with idiopathic thombocytopenic purpura: a causal association? J. Neurol. 257(3), 488–489 (2010).
   PubMed Web of Science ®Google Scholar
• Ravaglia S, Corso A, Piccolo G et al. Immune-mediated neuropathies in myeloma patients treated with bortezomib. Clin. Neurophysiol. 119(11), 2507–2512 (2008).
   PubMed Web of Science ®Google Scholar
• Khiani V, Kelly T, Shibli A, Jensen D, Mohanty SR. Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon α-2a therapy for chronic hepatitis C virus infection. World J. Gastroenterol. 14(2), 318–321 (2008).
   PubMed Web of Science ®Google Scholar
• Victor F, Menon K, Latkowski JA, Fernandez-Obregon A, Strober BE. Efalizumab-associated Guillain–Barré syndrome. Arch. Dermatol. 144(10), 1396–1397 (2008).
   PubMedGoogle Scholar
• Turatti M, Tamburin S, Idone D, Praitano ML, Zanette G. Guillain–Barré syndrome after short-course efalizumab treatment. J. Neurol. 257(8), 1404–1405 (2010).
   PubMed Web of Science ®Google Scholar
• Chu WM. Tumor necrosis factor. Cancer Lett. 328(2), 222–225 (2013).
   PubMed Web of Science ®Google Scholar
• Kollias G, Douni E, Kassiotis G, Kontoyiannis D. On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol. Rev. 169, 175–194 (1999).
   PubMed Web of Science ®Google Scholar
• Stübgen JP. Tumor necrosis factor-α antagonists and neuropathy. Muscle Nerve 37(3), 281–292 (2008).
   PubMed Web of Science ®Google Scholar
• Shin IS, Baer AN, Kwon HJ, Papadopoulos EJ, Siegel JN. Guillain–Barré and Miller Fisher syndromes occurring with tumor necrosis factor α antagonist therapy. Arthritis Rheum. 54(5), 1429–1434 (2006).
   PubMed Web of Science ®Google Scholar
• Manganelli S, Rossi M, Tuccori M, Galeazzi M. Guillain–Barré syndrome following adalimumab treatment. Clin. Exp. Rheumatol. 30(4), 592 (2012).
   PubMed Web of Science ®Google Scholar
• Wakerley BR, Yuki N. Anti-TNF-α therapy itself does not trigger Guillain–Barré syndrome. Clin. Exp. Rheumatol. 31(3), 475 (2013).
   PubMed Web of Science ®Google Scholar
• Rodriguez V, Kuehnle I, Heslop HE, Khan S, Krance RA. Guillain–Barré syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 29(6), 515–517 (2002).
   PubMed Web of Science ®Google Scholar
• Openshaw H, Slatkin NE, Stein AS, Hinton DR, Forman SJ. Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia. Cancer 78(9), 1899–1905 (1996).
   PubMed Web of Science ®Google Scholar
• Donofrio PD, Wilbourn AJ, Albers JW, Rogers L, Salanga V, Greenberg HS. Acute arsenic intoxication presenting as Guillain–Barré-like syndrome. Muscle Nerve 10(2), 114–120 (1987).
   PubMed Web of Science ®Google Scholar
• Gensicke H, Datta AN, Dill P, Schindler C, Fischer D. Increased incidence of Guillain–Barré syndrome after surgery. Eur. J. Neurol. 19(9), 1239–1244 (2012).
   PubMed Web of Science ®Google Scholar
• Wakerley BR, Yuki N. Surgery itself does not trigger Guillain–Barré syndrome. Eur. J. Neurol. 20(3), e40 (2013).
   PubMed Web of Science ®Google Scholar
• Angele MK, Faist E. Clinical review: immunodepression in the surgical patient and increased susceptibility to infection. Crit. Care 6(4), 298–305 (2002).
   PubMed Web of Science ®Google Scholar
• Cook CH, Martin LC, Yenchar JK et al. Occult herpes family viral infections are endemic in critically ill surgical patients. Crit. Care Med. 31(7), 1923–1929 (2003).
   PubMed Web of Science ®Google Scholar
• Miscusi M, Currà A, Della Rocca C, Missori P, Petrozza V. Acute motor-sensory axonal neuropathy after cervical spine surgery. J. Neurosurg. Spine 17(1), 82–85 (2012).
   PubMed Web of Science ®Google Scholar